Cargando…
Antitubercular therapy decreases nitric oxide production in HIV/TB coinfected patients
BACKGROUND: Nitric oxide (NO) production is increased among patients with human immunodeficiency virus (HIV) infection and also among those with tuberculosis (TB). In this study we sought to determine if there was increased NO production among patients with HIV/TB coinfection and the effect of four...
Autores principales: | Wanchu, A, Bhatnagar, A, Khullar, M, Sud, A, Bambery, P, Singh, S |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC119853/ https://www.ncbi.nlm.nih.gov/pubmed/12147177 http://dx.doi.org/10.1186/1471-2334-2-15 |
Ejemplares similares
-
Text messaging to decrease tuberculosis treatment attrition in TB-HIV coinfection in Uganda
por: Hermans, Sabine M, et al.
Publicado: (2017) -
Elevated Notch ligands in serum are associated with HIV/TB coinfection
por: Bermick, Jennifer R., et al.
Publicado: (2021) -
HIV Is Associated with Modified Humoral Immune Responses in the Setting of HIV/TB Coinfection
por: van Woudenbergh, Esther, et al.
Publicado: (2020) -
Incidence of socially significant infectious diseases (HIV, TB and HIV/TB coinfection) in the Arctic regions of Russia)
por: Zagdyn, Z., et al.
Publicado: (2021) -
The Medication Experience of TB/HIV Coinfected Patients: Qualitative Study
por: de Resende, Natália Helena, et al.
Publicado: (2022)